EUVIMEDEUVIMED entdecken
Crossref

Effects of chemotherapy counseling in breast cancer patients by pharmacist

Kanokkoj Budnampet

Isan Journal of Pharmaceutical Sciences, IJPS (Isan J Pharm Sci) · 01.01.2025

DOI: 10.14456/ijps.2025.7 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Isan Journal of Pharmaceutical Sciences, IJPS (Isan J Pharm Sci), erschienen am 01.01.2025. Verfasst von Kanokkoj Budnampet.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Breast cancer is the most common cancer among women. General treatment typically involves surgery, with some patients also requiring one of chemotherapy, radiotherapy, hormonal therapy or combination of these. However, non-compliance, often stemming from a lack of information and fear, can lead to recurrence and metastasis. Therefore, multidisciplinary care teams, incorporating pharmacists to provide information and counseling on cancer treatment, are crucial for improving patient adherence.

Objectives

To compare pre-test and post-test knowledge scores regarding chemotherapy among breast cancer patients following pharmacist-led counseling. Additionally, this study aimed to assess treatment compliance, and the severity and management of adverse drug reaction (ADRs) to chemotherapy.

Method

This prospective, descriptive study included 41 patients undergoing surgery during October 2018 to October 2019 at Nopparat Rajathanee Hospital. Patients received chemotherapy counseling from a pharmacist on two occasions: first, post-surgery (within one week) and second, at their follow-up appointment. Pretest and posttest scores were collected. ADRs were documented for patients receiving chemotherapy.

Results

Among 41 patients, the median post-counseling knowledge score (9 points) was significantly higher than the pre-counseling score (7 points) (p < 0.001). A significant improvement (p = 0.001) was observed in the correct response to the question: ‘Is chemotherapy necessary for all cancer patients?’ Most patients (95.1%) initiated or continued chemotherapy/hormonal therapy on schedule; 4.9% experienced delays due to other medical procedures. The most frequently reported ADRs were gastrointestinal, including nausea (36.6%) and vomiting (22%). Most ADRs were non-severe. The highest severity reported was grade 3 vomiting (2.4%), requiring hospitalization.

Conclusion

Pharmacist-led counseling contributed to improve patient knowledge regarding chemotherapy and supported the timely continuation of chemotherapy/hormonal therapy.

Schlagwörter

breast cancerpharmacist counselingpatient educationchemotherapy side effects

Zitieren

APA

Budnampet, K. (2025). Effects of chemotherapy counseling in breast cancer patients by pharmacist. Isan Journal of Pharmaceutical Sciences, IJPS (Isan J Pharm Sci). https://doi.org/10.14456/ijps.2025.7

Vancouver

Budnampet K. Effects of chemotherapy counseling in breast cancer patients by pharmacist. Isan Journal of Pharmaceutical Sciences, IJPS (Isan J Pharm Sci). 2025. doi:10.14456/ijps.2025.7

BibTeX
@article{Budnampet2025,
  author = {Budnampet, Kanokkoj},
  title = {Effects of chemotherapy counseling in breast cancer patients by pharmacist},
  journal = {Isan Journal of Pharmaceutical Sciences, IJPS (Isan J Pharm Sci)},
  year = {2025},
  doi = {10.14456/ijps.2025.7}
}
Kostenlos starten →